ÂÜÀòÂÒÂ×

The Research and Clinical Operations team at Biosceptre is responsible for advancing the understanding and therapeutic targeting of the nf-P2X7 cancer marker. This team oversees preclinical research initiatives, manages clinical trial design and execution, and ensures regulatory compliance, ultimately aiming to develop innovative treatments that selectively target cancerous tissues while sparing healthy ones. Leveraging their expertise, they work collaboratively to drive the translation of scientific discoveries into effective clinical applications.